Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

How to access Pharma in Focus articles
  • If you're a current subscriber, See below

  • If you're new to Pharma in Focus, Click here

  • If you haven't SUBSCRIBED yet, Click here

Current Subscribers

If you are are current Full Text Subscriber or have taken out a Free Trial, please type your email address into the form below.

This will restore your access and return you to the Home Page.

Email Address
Debating Point
Code under question
The Medicines Australia Code of Conduct imposes significant restrictions on what members of the association can do but is the compliance load it represents becoming too big a burden, sometimes for those who are not even a party to it.
Approvals Action
Generics makers add to brands
In a week when originators stayed on the sidelines generics makers added new brands to the ARTG.
Pipeline Monitor
Roche given FDA go-ahead in lung cancer
Roche has received approval to enter the second-line NSCLC race against BMS and MSD while Shire gains access to the pancreatic cancer market in Europe with Onivyde.
Debating Point
Australia's hidden 'free' drug system
Australia's pharmaceutical industry is giving away billions of dollars worth of drugs each year and almost no-one outside industry and government knows about it.